Bristol-Myers Squibb Co. will pay BioNTech SE as much as $11.1 billion to license a next-generation cancer drug, as competition intensifies in an area of oncology that seeks to harness the immune ...

Bristol-Myers makes an $11 billion deal with BioNTech to join the new cancer-treatment game, nearly double the size of Pfizer’s deal announced two weeks earlier.

Bristol will pay $1.5 billion up front to BioNTech for a 50% share in the profits and losses from BNT327. BMS will also pay BioNTech up to $2 billion in annual payments through 2028.

The NHRA Thunder Valley Nationals are running June 6-8 at Bristol Motor Speedway. Here's how to get the most out of the weekend as a fan.

The Super Grip NHRA Thunder Valley Nationals are set for June 6-8 at Bristol Motor Speedway, bringing some of the fastest cars in the world to Bristol, Tennessee. Some fans may be making their way ...

It's game day. Bath Rugby host Bristol Bears on Friday night in the semi-final of the 2024/25 Gallagher Premiership in the biggest derby clash in a generation.. Bath Rugby come into the game after ...

Bristol meanwhile finished in the final play-off spot in fourth. They beat Harlequins 52-26 at home on the final day of the regular season last weekend to book their place in the semi-finals.

Trams and light rail are “on the table” for Bristol following a major boost for the city’s hopes of a mass transit system. The Treasury will today (June 4) announce almost £800million of ...

Michael Schumacher's wife Corinna has shared her surprise after the "far too lenient" sentencing of a former security guard, Yilmaz T, who was given three years in prison following his role in a ...

BioNTech SE (NASDAQ:BNTX) and Bristol Myers Squibb & Co. (NYSE:BMY) entered into a co-development and co-commercialization agreement. The pact focuses on BioNTech’s investigational bispecific ...

Bristol Myers Squibb has agreed to pay up to $11.1 billion to partner with Germany's BioNTech and develop the latter's next-generation cancer immunotherapy, which could take on rival Merck & Co's ...